Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 6, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	67,363	78,940	92,210	84,776	173,804
Market Cap Growth	-33.62%	-14.39%	8.77%	-51.22%	-
Enterprise Value	75,898	83,717	97,706	80,968	-
Last Close Price	1414.00	1657.00	2170.00	2015.00	4880.00
PS Ratio	1.75	2.18	10.32	4.43	10.97
PB Ratio	2.24	2.51	3.28	2.22	10.66
P/TBV Ratio	6.07	6.66	5.17	3.27	10.79
P/FCF Ratio	-	-	-	-	46.85
P/OCF Ratio	-	-	-	-	39.18
EV/Sales Ratio	1.97	2.31	10.93	4.23	-
Debt / Equity Ratio	0.42	0.40	0.46	0.24	0.06
Debt / EBITDA Ratio	-	-	-	-	0.26
Debt / FCF Ratio	-	-	-	-	0.26
Asset Turnover	0.69	0.75	0.19	0.54	-
Inventory Turnover	22.54	27.11	4.82	7.83	-
Quick Ratio	0.45	0.65	2.07	1.50	5.38
Current Ratio	0.76	1.16	3.82	2.12	6.34
Return on Equity (ROE)	-24.90%	-26.95%	-30.26%	-12.85%	-
Return on Assets (ROA)	-7.66%	-8.56%	-10.81%	-6.46%	-
Return on Capital (ROIC)	-9.06%	-9.75%	-11.41%	-7.03%	-
Return on Capital Employed (ROCE)	-	-	-	-	17.50%
Earnings Yield	-12.14%	-9.70%	-10.37%	-3.98%	-6.35%
FCF Yield	-1.96%	-2.34%	-7.00%	-21.93%	2.14%
Buyback Yield / Dilution	-10.18%	-10.55%	-6.50%	-26.52%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.